end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsReceivableNetCurrent,AdditionalPaidInCapital,AllocatedShareBasedCompensationExpense,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,Depreciation,DueToOfficersOrStockholdersNoncurrent,EarningsPerShareBasicAndDiluted,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInAccountsReceivable,IssuanceOfStockAndWarrantsForServicesOrClaims,Liabilities,LiabilitiesAndStockholdersEquity,MarketingExpense,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingIncomeLoss,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquireRestrictedCertificatesOfDeposit,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfPrivatePlacement,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCashAndInvestmentsCurrent,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares,SharePrice,StockholdersEquity,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueOther
2021-09-30,2021-11-15,10-Q,"IR-Med, Inc.",IRME,CIK0001839133,USD,238000.0,109000.0,7400000.0,139000.0,3696000.0,3671000.0,3550000.0,3550000.0,,0.64,0.001,250000000.0,64601649.0,64601649.0,64000.0,,170000.0,-0.01,,287000.0,,,,408000.0,3696000.0,61000.0,,,,-730000.0,-8000.0,-722000.0,,,,,25000.0,374000.0,12000.0,-4176000.0,,,,,,0.26,3288000.0,,
